fbpx

Bio & Life Sciences The Pandemic

COVID-19 Testing: Good, Bad, and Downright Frustrating

Even dramatically increased testing capacity has been no match for poor strategy and misdirected deployment of tests in the U.S.   More

Analytics & Data Bio & Life Sciences The Pandemic

Could a Schizophrenia Treatment Conquer COVID-19?

Scientists are analyzing previously approved drugs to see if they have any effect against the SARS-CoV-2 virus. They might be onto something.   More

Bio & Life Sciences Healthcare Resilience Techonomy Events

Making the World a Healthier Place through Digital Health

Moderated by W2O’s Aaron Strout, panel participants include Melissa Opraseuth, Chief Operating Officer at par8o and Jennifer Lavanture, Vice President of Business Development at MedRhythms. Panelists will discuss how the technology’s promise of advancing healthcare is being realized at both their companies and how this sector will evolve over the next couple of years.   More

Analytics & Data Bio & Life Sciences Healthcare

How Google Thinks About Digital Health

A leader in some of Alphabet’s health-focused initiatives recently offered an update on ways the search and data giant can use information and digital tools to improve outcomes for individuals and society.   More

Bio & Life Sciences The Pandemic

Science Is What Determined a Successful Public Response to COVID-19

Some leaders saw that flattening the curve wouldn’t work against the pandemic. Others were reluctant to test at all. Scientific data made the difference between responses that worked, and those that didn’t.   More

Bio & Life Sciences Healthcare The Pandemic

Five Things Genomics Has Taught Us About COVID-19

‘Everything is unprecedented about the pandemic, and genomics is no exception,’ says an infectious disease expert. Genome sequencing has enabled scientists to track the virus, study its origins, confirm reinfection, and get to know more about it than has been learned about any organism in such a short time.   More

Bio & Life Sciences Community Insights Global Tech

We Need a New International Organization: The Science Readiness Reserves

COVID-19 is a wake-up call for institutional renewal and reform. The only way to face the uncertainties of the future is to build more, stronger public-private partnerships, and on a global basis.   More

Bio & Life Sciences Healthcare Innovation

Your Camera Knows You’re the Picture of Health–or If You Have COVID

Several companies are developing technology that can read your vital signs (and screen for COVID) via your smartphone camera simply by looking at your face.   More

Bio & Life Sciences Healthcare

Science Association Chief Very Worried about COVID’s Impact on Research

The president of the American Association for the Advancement of Science says the pandemic’s toll on non-COVID science is ‘a huge hit.’. Many research studies shut down midway, possibly turning results into a total loss.   More

Bio & Life Sciences Healthcare

For All Its Promise, Genomic Testing Is Struggling

For both clinical and consumer markets, genomic testing has a lot to offer — but it isn’t always used where it could be valuable, and people don’t understand it well enough. As a result, demand is dwindling in some areas.   More

Bio & Life Sciences Healthcare The Pandemic

A COVID Vaccine? Six Things to Watch

A good COVID-19 vaccine is the game-changer we all want and need. Here are six things to watch as the process unfolds.   More

Bio & Life Sciences Healthcare Science

How America’s Low Science Literacy Fueled the COVID Crisis

Americans have an uneasy relationship with science, and it’s influenced our sorry response to the COVID-19 pandemic. What could we do to improve the situation?   More

Bio & Life Sciences Healthcare Mobile

Why Americans Hate Contact Tracing

Americans are about as likely to report they’ve had Covid-19 and turn over their contacts as they are to report they’ve got head lice or STDs.   More

Bio & Life Sciences Innovation Manufacturing

Broaden Your View of Biology– It Could Soon Drive $4 Trillion in Value

A new report on the “bio revolution” finds that bio-based production of goods will have major economic impact over the next 20 years, and help combat climate change.   More

Bio & Life Sciences Healthcare

Genetic Counselors Embrace Tech to Help More Patients

To meet demand for interpretation of genetic tests, counselors are turning to chatbots, telemedicine, and more. A new grant opportunity from the NIH is another major boost.   More

Bio & Life Sciences Healthcare Internet of Things

Now Every Doctor’s a “Teledoc” But What’s Next?

Before the pandemic less than 10% of the American population had tried telehealth services. Most of us felt telehealth generally wasn’t much more than a doctor-directed self examination.  “Where does it hurt?  Do you have a fever? ”  A typical session via companies like Teladoc, Amwell or HealthTap took 15 minutes and cost something like […]   More

Bio & Life Sciences Healthcare

As We Wait For a Vaccine, Scientists Eye Antibodies

Antibody-based therapies may pave the way out of pandemic lockdown regardless of how soon a vaccine is available. ‘The science has been really blazing fast,’ says one expert.   More

Bio & Life Sciences Science

Antibody Tests Could Release Us from Lockdown (But Don’t Expect Immunity Passports)

Antibody testing for COVID-19 is touted as the path to pulling countries out of lockdown, but results so far have been unreliable. A public health expert explains how we can improve test accuracy, how tests should be used, and whether immunity certificates are in our future.   More

Bio & Life Sciences Healthcare

Next Time, Genomics Could Help Develop Vaccines Beforehand

If the COVID-19 pandemic has taught us anything, it’s that early detection and early action are vital, and that vaccines are what we need most. That’s why we should roll out pathogen surveillance programs based on genome sequencing tools.   More

Bio & Life Sciences Healthcare Resilience

A New Kind of COVID-19 Test Could Get Health Workers Back in Action

Another sort of test is possible. By looking at who’s already had COVID-19, rather than who has it now, we could help healthcare workers stay on the job.   More